USPTO serial 79278623
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological and chemical substances used in industry and for scientific and research purposes, including medical scientific and medical research purposes | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations; dietetic substances adapted for medical use, in-vitro diagnostic preparations for medical purposes; sanitary preparations | ACTIVE | — |
| 035 | Services in the field of data processing; all of the aforementioned services only in the field of clinical, veterinary, environmental and medical diagnosis | ACTIVE | — |
| 042 | Scientific and technological services and research services, including consultancy services for scientific, technical laboratory and research purposes; laboratory research services, laboratory testing services, development of computer hardware and software; all of the aforementioned services only in the field of clinical, veterinary, environmental and medical diagnosis | ACTIVE | — |
| 044 | Consultancy services for health and medical purposes; services in the field of medicine, health care; health centers; medical care | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2021 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 1, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 1, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 27, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 16, 2021 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Dec 15, 2020 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 24, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Oct 1, 2020 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 1, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 18, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 3, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 13, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 13, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 22, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 21, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 20, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 18, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 18, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 13, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |